IN RARE FOR LIFE
Dead / Abandoned — Abandoned — no statement of use filed (as of 10 Aug 2023)
What this means for you
This application is over — abandoned 10 Aug 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90166041
- Mark type
- Stylized text
- Filed
- 08 Sept 2020
- Published for opposition
- 15 Dec 2020
- Abandoned
- 10 Aug 2023
- Attorney of record
- Jared M. Barrett
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention of liver diseases and disorders; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the prevention of kidney diseases and disorders; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the prevention of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the prevention of monogenic diseases and disorders; pharmaceutical preparations for the treatment of monogenic diseases and disorders; pharmaceutical preparations for the prevention of metabolic diseases and disorders; pharmaceutical preparations for the treatment of metabolic diseases and disorders; therapeutic preparations for the prevention of liver diseases and disorders; therapeutic preparations for the treatment of liver diseases and disorders; therapeutic preparations for the prevention of kidney diseases and disorders; therapeutic preparations for the treatment of kidney diseases and disorders; therapeutic preparations for the prevention of central nervous system diseases and disorders; therapeutic preparations for the treatment of central nervous system diseases and disorders; therapeutic preparations for the prevention of monogenic diseases and disorders; therapeutic preparations for the treatment of monogenic diseases and disorders; therapeutic preparations for the prevention of metabolic diseases and disorders; therapeutic preparations for the treatment of metabolic diseases and disorders
Owner
- TRAVERE THERAPEUTICS, INC., San Diego, CA, US
- Retrophin, Inc., San Diego, CA, US
- Retrophin, Inc., San Diego, CA, US
Prosecution history
- 13 Feb 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 13 Feb 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 13 Jan 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Jan 2023 — SOU EXTENSION 4 GRANTED
- 05 Jan 2023 — SOU EXTENSION 4 FILED
- 05 Jan 2023 — SOU TEAS EXTENSION RECEIVED
- 16 Aug 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Aug 2022 — SOU EXTENSION 3 GRANTED
- 04 Aug 2022 — SOU EXTENSION 3 FILED
- 04 Aug 2022 — SOU TEAS EXTENSION RECEIVED
- 06 Jan 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Jan 2022 — SOU EXTENSION 2 GRANTED
- 15 Dec 2021 — SOU EXTENSION 2 FILED
- 05 Jan 2022 — DIVISIONAL PROCESSING COMPLETE
- 15 Dec 2021 — DIVISIONAL REQUEST RECEIVED